3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
45
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Myelodysplastic Syndromes
26
Recurrence
18
Multiple Myeloma
18
Lymphoma, Non-Hodgkin
15
Lymphoma, B-Cell
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma
14
Ovarian Neoplasms
12
Hematologic Neoplasms
12
Pancreatic Neoplasms
10
Melanoma
10
Hodgkin Disease
10
Myeloproliferative Disorders
9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
9
Burkitt Lymphoma
9
Stomach Neoplasms
8
Lymphoma, Large B-Cell, Diffuse
8
Neoplasms
7
Lymphoma, Mantle-Cell
7
Lymphoma, Follicular
7
Leukemia, Biphenotypic, Acute
7
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasm Metastasis
6
Leukemia, Myelomonocytic, Juvenile
6
Leukemia, Myelomonocytic, Chronic
6
Breast Neoplasms
6
Interventions
Rituximab
2
Radiotherapy, Intensity-Modulated
2
pomalidomide
1
dehydroftorafur
1
Watchful Waiting
1
Vincristine
1
Taxes
1
Prednisone
1
Platinum
1
Phantoms, Imaging
1
Paclitaxel
1
Nivolumab
1
Matrix-M
1
Magnetic Resonance Spectroscopy
1
Gemcitabine
1
Fluorouracil
1
Etoposide
1
Doxorubicin
1
Cyclophosphamide
1
Cisplatin
1
Cell Count
1
Blood Specimen Collection
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Epstein-Barr Virus Infections
×
fludarabine
×
90 days
×
Clear all
No trials found.